Stockreport

Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates

Amicus Therapeutics, Inc.  (FOLD) 
Last amicus therapeutics, inc. earnings: 11/11 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.amicusrx.com/investor-relations
PDF 2019 Galafold Revenue Nearly Doubled to $182.2M On Track to Achieve 2020 Revenue Guidance of $250M-$260M Focused on Pompe Phase 3 PROPEL Study, Manufacturing to Suppor [Read more]